
CVD may interfere with an eye care provider’s ability to differentiate between choroidal melanoma and choroidal nevus

CVD may interfere with an eye care provider’s ability to differentiate between choroidal melanoma and choroidal nevus


Researchers note work may lead to targets for conventional outflow pathway therapies.

Therapeutics can prevent vision loss and neurodegeneration in patients.

Researchers train deep learning model on OCT scans to ID patients eligible for GA trials.

The purpose of the study was to determine if experience affects the surgeons’ dexterity response to pharmacologic and behavioral interventions.

The key factor may be the control of inflammation.

Investigators conducted a case-control study to investigate the corneal topography parameters and biomechanics in patients with alopecia areata

A novel formulation may prevent blood vessel growth and vascular leakage in the retina.

Prescriptions with semaglutide (Wegovy, Ozempic, Novo Nordisk) are FDA approved to treat obesity and type 2 diabetes, respectively.

NVK002 atropine 0.01% (Vyluma Inc.) “meaningfully slowed” myopia progression in myopic pediatric patients over a 36-month period.

Technology offers increased usability, safety, and accuracy in MIGS procedures.

Comanagement is a key component for treatment of disease.

The SimVis Gekko eye dominance strength test may change the standard of care.

From amniotic membrane grafting to neurotization.

Repeated 0.1-ml intravireal injections of lampalizumab, antigen-binding fragment of a humanized monoclonal antibody that inhibits complement factor D, seem to be associated with a low risk of elevated IOP

Plasma emission for blepharitis, meibomian gland dysfunction, and dry eye disease.



Durable treatments impact the quality of life of patients with retinal diseases.

The adaptor was tested by low-vision patients and participants with simulated visual impairment.

Physicians wonder whether normal examination results are actually normal.

Phase 1 multicenter study demonstrates early signs of efficacy.

Investigators looked to see if a large language model could provide safe, accurate, and readable information to patient inquiries about cataract surgery.

The retrospective real-world evaluation of the drug considered several important as-yet-unanswered questions

The mapping method revealed prominent microscopic abnormalities consistent with diabetic retinopathy.

Low birth weight, blood transfusion, necrotising enterocolitis, bronchopulmonary dysplasia and antenatal steroid and surfactant therapies are among the factors that affect the development of ROP.

Investigators put forth a list of considerations for surgeons ahead of lens removal in pediatric patients

Authors pointed out that understanding this link may aid with genetic counseling or surveillance of affected individuals, potentially contributing to improved management and outcomes.

The high-level analysis found that 82% of TEPEZZA-treated patients in the follow-up did not report needing any additional TED treatment for nearly 2 years.